adenine has been researched along with Chronic Delta Hepatitis in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The first choice of therapy in chronic hepatitis B infection can be pegylated interferon for 48 weeks or continuous entecavir or tenofovir therapy." | 3.80 | [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline]. ( Gervain, J; Horváth, G; Hunyady, B; Lengyel, G; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I, 2014) |
| "Interferon is the only effective treatment for chronic hepatitis D virus (HDV) infection." | 2.80 | Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome. ( Bozkaya, H; Dalekos, GN; Deda, X; Gürel, S; Heidrich, B; Idilman, R; Keskin, O; Manns, M; Pehlivan, S; Tabak, F; Tüzün, A; Wedemeyer, H; Yalçın, K; Yurdaydin, C; Zachou, K; Zeuzem, S, 2015) |
| "Liver fibrosis was measured using elastometry." | 1.40 | Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients. ( Barreiro, P; Fernández-Montero, JV; Labarga, P; Mendoza, Cd; Sierra-Enguita, R; Soriano, V; Vispo, E, 2014) |
| "Data on liver fibrosis evolution in HIV-HBV-coinfected patients treated with tenofovir disoproxil fumarate (TDF) are scarce." | 1.36 | Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use. ( Bonnard, P; Boyd, A; Girard, PM; Lacombe, K; Lascoux-Combe, C; Lasnier, E; Meynard, JL; Miailhes, P; Molina, JM; Wendum, D, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brichler, S | 1 |
| Setshedi, M | 1 |
| Renou, C | 1 |
| Gunsar, F | 1 |
| Price, J | 1 |
| Horváth, G | 1 |
| Hunyady, B | 1 |
| Gervain, J | 1 |
| Lengyel, G | 1 |
| Makara, M | 1 |
| Pár, A | 1 |
| Szalay, F | 1 |
| Telegdy, L | 1 |
| Tornai, I | 1 |
| Soriano, V | 1 |
| Vispo, E | 1 |
| Sierra-Enguita, R | 1 |
| Mendoza, Cd | 1 |
| Fernández-Montero, JV | 1 |
| Labarga, P | 1 |
| Barreiro, P | 1 |
| Keskin, O | 1 |
| Wedemeyer, H | 3 |
| Tüzün, A | 1 |
| Zachou, K | 3 |
| Deda, X | 1 |
| Dalekos, GN | 2 |
| Heidrich, B | 1 |
| Pehlivan, S | 1 |
| Zeuzem, S | 2 |
| Yalçın, K | 1 |
| Gürel, S | 2 |
| Tabak, F | 1 |
| Idilman, R | 1 |
| Bozkaya, H | 2 |
| Manns, M | 1 |
| Yurdaydin, C | 3 |
| Goyal, A | 1 |
| Murray, JM | 1 |
| Cholongitas, E | 1 |
| Goulis, I | 1 |
| Antoniadis, N | 1 |
| Fouzas, I | 1 |
| Imvrios, G | 1 |
| Giakoustidis, D | 1 |
| Giouleme, O | 1 |
| Papanikolaou, V | 1 |
| Akriviadis, E | 1 |
| Vasiliadis, T | 1 |
| Valencia, ME | 1 |
| Moreno, V | 1 |
| Mansour, W | 1 |
| Ducancelle, A | 1 |
| Le Gal, F | 1 |
| Le Guillou-Guillemette, H | 1 |
| Abgueguen, P | 1 |
| Pivert, A | 1 |
| Calès, P | 1 |
| Gordien, E | 1 |
| Lunel, F | 1 |
| Boyd, A | 1 |
| Lasnier, E | 1 |
| Molina, JM | 1 |
| Lascoux-Combe, C | 1 |
| Bonnard, P | 1 |
| Miailhes, P | 1 |
| Wendum, D | 1 |
| Meynard, JL | 1 |
| Girard, PM | 1 |
| Lacombe, K | 1 |
| Erhardt, A | 1 |
| Çakaloğlu, Y | 1 |
| Değertekin, H | 1 |
| Koch, A | 1 |
| Bock, T | 1 |
| Dienes, HP | 1 |
| Manns, MP | 2 |
| Grabowski, J | 1 |
| Buggisch, P | 1 |
| Hofmann, WP | 1 |
| Jaroszewicz, J | 1 |
| Schlaphoff, V | 1 |
| Cornberg, M | 1 |
| Ferenci, P | 1 |
| Grattagliano, I | 1 |
| Palmieri, VO | 1 |
| Portincasa, P | 1 |
| Palasciano, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter Randomised Study Comparing the Efficacy of PegIFN-alfa2a Plus Placebo vs. PegIFN-alfa2a Plus Tenofovir for the Treatment of Chronic Delta Hepatitis-The Hep-Net International Delta Hepatitis Interventional Trial II (HIDIT-II)[NCT00932971] | Phase 2 | 70 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for adenine and Chronic Delta Hepatitis
| Article | Year |
|---|---|
Treatment of delta hepatitis.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Farnesyl-Diphosphate Farnesyltransferase; Hepa | 2013 |
An update on hepatitis B, D, and E viruses.
Topics: Adenine; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis E | 2014 |
Treatment of chronic viral hepatitis.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; He | 2004 |
3 trials available for adenine and Chronic Delta Hepatitis
| Article | Year |
|---|---|
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.
Topics: Adenine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatiti | 2015 |
Peginterferon plus adefovir versus either drug alone for hepatitis delta.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Analysis of Variance; Antiviral Agents; Drug Therapy, Co | 2011 |
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
Topics: Adenine; Adult; Analysis of Variance; Antiviral Agents; Cells, Cultured; Chi-Square Distribution; Cy | 2011 |
9 other studies available for adenine and Chronic Delta Hepatitis
| Article | Year |
|---|---|
Resolution of chronic hepatitis delta infection after five years of peginterferon-adefovir: lessons from a case report.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis D, Chronic; Hepatitis de | 2013 |
[Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
Topics: Adenine; Antiviral Agents; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Evide | 2014 |
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients.
Topics: Adenine; Adult; Antiviral Agents; Hepatitis D, Chronic; HIV Infections; Humans; Liver Cirrhosis; Mal | 2014 |
Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China.
Topics: Adenine; Adult; Age Factors; Aged; Antiviral Agents; China; Cohort Studies; Cost of Illness; Cost-Be | 2016 |
Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
Topics: Adenine; Adult; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Guanin | 2016 |
[Atazanavir-induced nephrolithiasis].
Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cy | 2009 |
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.
Topics: Adenine; Antibodies, Viral; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; | 2010 |
Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort | 2010 |
Adefovir dipivoxyl for the treatment of delta-related liver cirrhosis.
Topics: Adenine; Female; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Liver Cirrhosis; Middle Aged; | 2006 |